Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perhexiline for severe aortic stenosis symptoms
ACTRN12606000004561Phase 4Active, not recruiting
- Sponsor
- The Queen Elizabeth Hospital,Cardiology Department
- Start
- Jun 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of perhexiline in aortic stenosis (AS) (2 arms), sponsored by The Queen Elizabeth Hospital,Cardiology Department. Primary endpoint: Symptomatic status. Started Jun 1999; status: active, not recruiting.
02
Drugs
perhexiline
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on ACTRN12606000004561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000004561.